These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 11805335

  • 1. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP, Bendix R, Chen P, Clark R, Dork T, Lavin MF.
    Proc Natl Acad Sci U S A; 2002 Jan 22; 99(2):925-30. PubMed ID: 11805335
    [Abstract] [Full Text] [Related]

  • 2. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
    Gutiérrez-Enríquez S, Fernet M, Dörk T, Bremer M, Lauge A, Stoppa-Lyonnet D, Moullan N, Angèle S, Hall J.
    Genes Chromosomes Cancer; 2004 Jun 22; 40(2):109-19. PubMed ID: 15101044
    [Abstract] [Full Text] [Related]

  • 3. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH.
    Cancer Res; 2001 Oct 15; 61(20):7608-15. PubMed ID: 11606401
    [Abstract] [Full Text] [Related]

  • 4. Functional consequences of sequence alterations in the ATM gene.
    Lavin MF, Scott S, Gueven N, Kozlov S, Peng C, Chen P.
    DNA Repair (Amst); 2004 Oct 15; 3(8-9):1197-205. PubMed ID: 15279808
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contributions of ATM mutations to familial breast and ovarian cancer.
    Thorstenson YR, Roxas A, Kroiss R, Jenkins MA, Yu KM, Bachrich T, Muhr D, Wayne TL, Chu G, Davis RW, Wagner TM, Oefner PJ.
    Cancer Res; 2003 Jun 15; 63(12):3325-33. PubMed ID: 12810666
    [Abstract] [Full Text] [Related]

  • 8. ATM mutations in cancer families.
    Vorechovský I, Luo L, Lindblom A, Negrini M, Webster AD, Croce CM, Hammarström L.
    Cancer Res; 1996 Sep 15; 56(18):4130-3. PubMed ID: 8797579
    [Abstract] [Full Text] [Related]

  • 9. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.
    Mitui M, Nahas SA, Du LT, Yang Z, Lai CH, Nakamura K, Arroyo S, Scott S, Purayidom A, Concannon P, Lavin M, Gatti RA.
    Hum Mutat; 2009 Jan 15; 30(1):12-21. PubMed ID: 18634022
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
    Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J.
    Clin Cancer Res; 2002 Dec 15; 8(12):3813-9. PubMed ID: 12473594
    [Abstract] [Full Text] [Related]

  • 12. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J.
    Cancer Lett; 2005 Sep 28; 227(2):105-14. PubMed ID: 16112413
    [Abstract] [Full Text] [Related]

  • 13. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
    Spring K, Ahangari F, Scott SP, Waring P, Purdie DM, Chen PC, Hourigan K, Ramsay J, McKinnon PJ, Swift M, Lavin MF.
    Nat Genet; 2002 Sep 28; 32(1):185-90. PubMed ID: 12195425
    [Abstract] [Full Text] [Related]

  • 14. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
    Broeks A, Braaf LM, Huseinovic A, Schmidt MK, Russell NS, van Leeuwen FE, Hogervorst FB, Van 't Veer LJ.
    Breast Cancer Res Treat; 2008 Jan 28; 107(2):243-8. PubMed ID: 17393301
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modeling ATM mutant proteins from missense changes confirms retained kinase activity.
    Barone G, Groom A, Reiman A, Srinivasan V, Byrd PJ, Taylor AM.
    Hum Mutat; 2009 Aug 28; 30(8):1222-30. PubMed ID: 19431188
    [Abstract] [Full Text] [Related]

  • 17. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK.
    Cancer Res; 2000 Jun 15; 60(12):3299-304. PubMed ID: 10866324
    [Abstract] [Full Text] [Related]

  • 18. The role of ATM in breast cancer development.
    Prokopcova J, Kleibl Z, Banwell CM, Pohlreich P.
    Breast Cancer Res Treat; 2007 Aug 15; 104(2):121-8. PubMed ID: 17061036
    [Abstract] [Full Text] [Related]

  • 19. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
    Vorechovský I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster AD, Yuille MA.
    Nat Genet; 1997 Sep 15; 17(1):96-9. PubMed ID: 9288106
    [Abstract] [Full Text] [Related]

  • 20. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL, Laugé A, Weber J, Champ J, Cavaciuti E, Russo A, Viovy JL, Stoppa-Lyonnet D.
    Breast Cancer Res Treat; 2010 Jan 15; 119(2):443-52. PubMed ID: 19404735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.